• RWD36 Time to Reimbursement in Kazakhstan for Novel Cancer Medicines Approved during the Period 2013-2022

    Jun 1, 2024, 00:00

  • HSD91 ‘It Is Not in Stock’: Identifying Determinants of Patient Deception in Community Pharmacies

    Jun 1, 2024, 00:00

  • Psychometric Properties of General Oral Health Assessment Index Across Ages: COSMIN Systematic Review

    Jun 1, 2024, 00:00

  • PCR173 Health State Utilities Associated With X-Linked Retinitis Pigmentosa in the United States

    Jun 1, 2024, 00:00

  • HPR40 Do State Direct Access Laws to Physical Therapy Influence Healthcare Utilization and Costs Among Medicare Patients With Atraumatic Rotator Cuff Tears? An Instrumental Variable Approach

    Jun 1, 2024, 00:00

  • HPR128 Benchmarking Clinical Trial Diversity: Methods to Characterize Eligibility-Based Representativeness

    Jun 1, 2024, 00:00

  • EE500 Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin, and Efgartigimod Alfa in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States

    Jun 1, 2024, 00:00

  • PCR248 Comparison of Quality of Life Scales after Stroke in Hungarian and International Practice

    Jun 1, 2024, 00:00

  • EPH69 Uptake of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among United States (US) Adults Following 2022 Update to Recommendations

    Jun 1, 2024, 00:00

  • CO148 The Impact of Approved Anti-Obesity Medications on Osteoarthritis Risk in Patients With Obesity: A Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • EE503 Real-World Treatment Patterns, Healthcare Resource Utilization (HCRU) and Healthcare Costs (HCC) of Patients with Small-Cell Lung Cancer (SCLC) in the US

    Jun 1, 2024, 00:00

  • EPH78 Lung Cancer Screening Eligibility and Use in the US: A Cross-Sectional Analysis of 2022 Behavioral Risk Factor Surveillance System Data

    Jun 1, 2024, 00:00

  • EE316 Economic Burden of Fabry Disease in Colombia

    Jun 1, 2024, 00:00

  • PCR178 Use of Patient Reported Outcomes in Registered Drug Studies for Long COVID

    Jun 1, 2024, 00:00

  • CO173 The Role of Mindfulness, Pelvic Floor Physical Therapy (PFPT), and Hypopressive Exercises for Chronic Pelvic Pain (CPP): Preliminary Results in Productivity Gain and Loss

    Jun 1, 2024, 00:00

  • PCR141 Smoldering Multiple Myeloma: A Multi-Country Mixed-Methods Study on Disease Perceptions and Patient Treatment Preferences

    Jun 1, 2024, 00:00

  • HTA12 Investigating the Influence of Therapy-Related Factors on Reimbursement Success: A Multi-Country Analysis

    Jun 1, 2024, 00:00

  • SA55 Efficacy and Tolerability of Contingency Management and Cognitive-Behavioral Therapy With Pharmacotherapy or Placebo in Managing Stimulant Use Disorder: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • HSD118 Real-World Treatment Patterns and Cardiovascular Disease (CVD) Burden in Patients With Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Receiving Covalent Bruton’s Tyrosine Kinase Inhibitors (cBTKis)

    Jun 1, 2024, 00:00

  • CO139 Comparative Effectiveness of Rapid Vs. Non-Rapid Start of Anti-Retroviral Therapy in Patients With Human Immunodeficiency Virus Infection on Clinical Outcomes: A Systematic Literature Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • CO11 Captopril Response Association With Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphisms in Mexican Indigenous

    Jun 1, 2024, 00:00

  • PCR110 Valuation of Child Health: A United States Value Set for the EQ-5D-Y-3L

    Jun 1, 2024, 00:00

  • EE141 Cost-Effectiveness of Pembrolizumab for Adjuvant Treatment of Patients With Renal-Cell Carcinoma Who Have Undergone Nephrectomy in Colombia

    Jun 1, 2024, 00:00

  • HPR132 Employer Perspectives on Alternative Funding Programs

    Jun 1, 2024, 00:00

  • EPH241 Benzodiazepines and Adrenergic beta2-Agonists: A Synergistic Impact on Health-Related Quality of Life Among Older Adults with Prostate Cancer

    Jun 1, 2024, 00:00

  • MSR15 Revolutionizing Systematic Literature Reviews: Harnessing the Power of Large Language Model (GPT-4) for Enhanced Research Synthesis

    Jun 1, 2024, 00:00

  • Patient Impact of Rare Diseases

    Jun 1, 2024, 00:00

  • HPR6 Inflation Reduction Act: How Will the First 10 Drugs Selected for Medicare Price Negotiations Impact US Commercial Payers?

    Jun 1, 2024, 00:00

  • EE133 Burden of Illness for Adults Living With Primary Chronic Immune Thrombocytopenia in the United States

    Jun 1, 2024, 00:00

  • EE403 Budget Impact of Selinexor Combination Regimens in Previously Treated Multiple Myeloma

    Jun 1, 2024, 00:00

  • EE271 Lifetime Productivity Loss Due to HIV Mortality in the United States

    Jun 1, 2024, 00:00

  • CO61 Analysis of Healthcare Resource Utilization in the NODE-303 Clinical Trial to Terminate Paroxysmal Supraventricular Tachycardia Episodes

    Jun 1, 2024, 00:00

  • EE123 Cost-Effectiveness of the Brexu-Cel in Relapsed/Refractory Mantle Cell Lymphoma and B-Cell Acute Lymphoblastic Leukemia: A Systematic Review

    Jun 1, 2024, 00:00

  • HPR36 Barriers to Getting New Cancer Medicines to Patients in Kazakhstan

    Jun 1, 2024, 00:00

  • EPH150 Post-Market Safety Assessment Associated with JAK Inhibitors of Xeljanz, Olumiant, and Rinvoq Using Faers Database from 2012 to 2022

    Jun 1, 2024, 00:00

  • MSR105 Proportional Randomization Method to Identify Index Line of Therapy in Externally Controlled Trials

    Jun 1, 2024, 00:00

  • EE234 Quality of Life and Burden of Epilepsy Patients in United States: A Comparative Study of Matched Case-Control Based on Medical Expenditure Panel Survey (MEPS), 2017-2021

    Jun 1, 2024, 00:00

  • EE493 Sociodemographic Factors of Asthma Prevalence and Costs for Children in the United States, 2016-2021

    Jun 1, 2024, 00:00

  • PCR200 Content Validity of FACT-GP5 to Assess Treatment Tolerability in Participants With Progressive, Advanced, Kinase Inhibitor-Naïve, RET-Mutant Medullary Thyroid Cancer: Qualitative Interview Sub-Study of the LIBRETTO-531 Trial

    Jun 1, 2024, 00:00

  • MSR45 Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients With Atrial Fibrillation and Cancer

    Jun 1, 2024, 00:00

  • EPH20 Trends in New Prescriptions for Opioids, Non-Opioids, and Opioid Antagonists in the United States, 2019 - 2023

    Jun 1, 2024, 00:00

  • PCR175 Screening for Anxiety and Depressive Symptoms in Adolescents With Complex Health Conditions From a Longitudinal Registry Study in Los Angeles County: Comparative Performance of the EQ-5D-5L and PedsQL

    Jun 1, 2024, 00:00

  • HSD84 Prescription Contraceptive Use Among Medicaid-Insured Women With Obesity in the United States

    Jun 1, 2024, 00:00

  • EE160 Evidence to Inform Forecasts of Biopharmaceutical Policy Impact

    Jun 1, 2024, 00:00

  • RWD99 Healthcare Costs of Cancer by Clinical Stage and Cost Component in a Private Health Plan in Brazil (Real World Data)

    Jun 1, 2024, 00:00

  • RWD58 Ketamine-Associated Adverse Events: An Analysis of the FAERS Database From 2012 - 2021

    Jun 1, 2024, 00:00

  • CO80 Using Machine Learning to Understand Predictors of Frequent Surveillance Testing in Colorectal Cancer Patients

    Jun 1, 2024, 00:00

  • HSD120 Effectiveness of Pharmacist-Led Interventions on Medication Use and Related Health Outcomes in Patients With Alzheimer's Disease and Related Dementias: A Systematic Review

    Jun 1, 2024, 00:00

  • EE106 Cost-Effectiveness Analysis of Belimumab for the Treatment of Adults With Active Lupus Nephritis in China

    Jun 1, 2024, 00:00

  • Economic Evaluation

    Jun 1, 2024, 00:00

  • HTA47 Assessing the Effectiveness and Cost of Future Technologies to Screen for Colorectal Cancer

    Jun 1, 2024, 00:00

  • RWD69 Utilization of Current Procedural Terminology Codes in Pharmacists' Services Using Medicare Data Claims

    Jun 1, 2024, 00:00

  • EE22 COPD-Related Healthcare Resource Utilization Before and After Initiating Inhaled Corticosteroid-Containing Maintenance Regimens: Real World Claims Data

    Jun 1, 2024, 00:00

  • RWD136 Regulatory Vs HTA Divergences- Can the Real-World Evidence (RWE) be the Connecting Bridge?

    Jun 1, 2024, 00:00

  • SA33 Real-World Comparison of Adherence and Persistence between Glucagon-like Peptide-1 Receptor Agonist (GLP-1) and Sodium-Glucose Cotransporter 2 (SGLT-2) in Patients with Type 2 Diabetes (T2D)

    Jun 1, 2024, 00:00

  • HPR21 Healthcare Expenditure and Its Association with Under Five Mortality: A Cross-Country Analysis in the Eastern Mediterranean Region

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • HTA82 Adjusting Utilities Using Age and Time-to-Death Decrements in Cost-Effectiveness Analyses: A Case Study in Relapsed and/or Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • HTA81 Assessing Evidence Packages of CRISPR Technologies: Will They Meet Payer Needs?

    Jun 1, 2024, 00:00

  • EE258 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) for High-Risk Patients in Chile

    Jun 1, 2024, 00:00

  • EE296 A United States Payer Budget Impact Analysis of Myocardial Perfusion Imaging Modalities Positron Emission Tomography with Flurpiridaz Compared to Single Photon Emission Computed Tomography in Coronary Artery Disease Diagnosis

    Jun 1, 2024, 00:00

  • CO67 Network Meta-Analysis to Compare the Efficacy Between Different Classes of PCSK9 Inhibitors, siRNA Vs. PCSK9 mAb, in Asian Patients With Hypercholesterolemia at Increased Cardiovascular Risk

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • RWD160 An Episode-Based Analysis in a Medicare Advantage Population to Identify the Cost Impact of Virtual-First Care for Common Acute Conditions

    Jun 1, 2024, 00:00

  • EPH134 Difference in E-Cigarette Use Prevalence in Adolescents between 2019 and 2021 in Georgia, United States

    Jun 1, 2024, 00:00

  • EPH169 Integrating Structured and Unstructured Data in Total Hip Arthroplasty Evaluation: A Comprehensive Analysis for Enhanced Device Safety

    Jun 1, 2024, 00:00

  • HSD9 Oncology Practice Setting Classification in the US: Considerations for Real World Evidence

    Jun 1, 2024, 00:00

  • EE79 Real-World Clinical and Economic Burden of Primary Biliary Cholangitis in the United States

    Jun 1, 2024, 00:00

  • RWD137 Automated Non-Interventional Research Protocol Generation: A Case Study in Melanoma

    Jun 1, 2024, 00:00

  • EPH190 Trends and Disparities in Perinatal Health Outcomes Among Women from Refugee Backgrounds in Victoria, Australia: A Population-Based Study

    Jun 1, 2024, 00:00

  • HTA19 A Targeted Review of NICE, CADTH and ICER Assessments: An Evaluation of the Joint Position Statement

    Jun 1, 2024, 00:00

  • HPR113 Equity in Antenatal Care Quality: An Analysis of 11.382 Cases from 23 Municipalities in Colombia

    Jun 1, 2024, 00:00

  • EPH1 High Throughput Screening for Roflumilast Adverse Effects in Real-World Settings: A Sequence Symmetry Analysis

    Jun 1, 2024, 00:00

  • PCR119 Treatment Persistence Among Treatment-Experienced People With HIV (PWH) Switching To Integrase Strand Transfer Inhibitor (INSTI)-Based HIV Antiretroviral Regimens

    Jun 1, 2024, 00:00

  • MT39 Reporting Characteristics of Randomized Controlled Trials of Endovascular Therapy for Peripheral Artery Disease: A Systematic Review

    Jun 1, 2024, 00:00

  • PCR238 Estimating Health State Utilities (HSUS) for Aromatic L-Amino Acid Decarboxylase Deficiency (AADCD) in the United States

    Jun 1, 2024, 00:00

  • RWD118 Implementation and Validation of a Prioritization Logic to Identify the Best Available Race/Ethnicity Information for Members in Commercial Plans

    Jun 1, 2024, 00:00

  • P27 Uptake and Costs of Rituximab Biosimilars Among the Medicare and Medicaid Populations in 2019-2021 in the United States

    Jun 1, 2024, 00:00

  • HPR55 Limiting the Potency of Delta-9-Tetrahydrocannabinol (THC) in Cannabis Products: What Policymakers Need to Know

    Jun 1, 2024, 00:00

  • P56 Extraction of Inflammatory Bowel Disease Severity Scores from Unstructured Clinical Notes Using a Retriever-Reader Architecture

    Jun 1, 2024, 00:00

  • EPH11 Determinants of Mammography Screening Participation– A Cross-Sectional Analysis of the Hungarian Sample

    Jun 1, 2024, 00:00

  • EE179 Cost Effectiveness of Mastectomies of BRCA1 and BRCA2 Positive Women over Olaparib

    Jun 1, 2024, 00:00

  • EE188 Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients with Non-Valvular Atrial Fibrillation in the United States

    Jun 1, 2024, 00:00

  • CO99 Validation of Overall Survival (OS) Extrapolations Using 5-Year Follow-up Data From the Keynote-177 MSI-H/dMMR Metastatic Colorectal Cancer (mCRC) Study

    Jun 1, 2024, 00:00

  • EE448 A Recent Adoption of Cost-Effectiveness Thresholds in Brazil and Its Repercussions

    Jun 1, 2024, 00:00

  • EE39 Economic Evaluation of Botulinum Toxin Type A (XEOMEEN) in the Treatment of Pediatric Patients With Spasticity in the "IMSS” and “ISSSTE”

    Jun 1, 2024, 00:00

  • EPH112 Prevalent Comorbidities and Disease-Related Conditions in Heavily Pre-Treated Patients With Multiple Myeloma: A Real-World Retrospective Database Analysis

    Jun 1, 2024, 00:00

  • SA22 Does the Use of Investigator-Choice Comparator Arms in Oncology Clinical Trials Influence Payer Assessments Outcomes?

    Jun 1, 2024, 00:00

  • EE85 Sources of Increased Expenditures for Young Children with Autism Spectrum Disorder Diagnoses in Employer-Sponsored Plans, 2016–2021

    Jun 1, 2024, 00:00

  • EE44 Outcomes and Cost-Effectiveness of Hospital Outpatient Versus Ambulatory Surgery Center Lumbar Decompression Surgery

    Jun 1, 2024, 00:00

  • PT38 Early and Mid-Term Outcome of Valve Replacement With Porcine Bioprosthesis in the Aortic Positions

    Jun 1, 2024, 00:00

  • RWD150 Tirzepatide and Weight Reduction Among Individuals without Evidence of Type 2 Diabetes: Descriptive Results from Optum’s De-Identified Market Clarity Data

    Jun 1, 2024, 00:00

  • PCR92 Association of Rheumatoid Arthritis (RA) Patient Characteristics and Perceived Treatment Satisfaction, RA Impact on Life, and Task Difficulty with Promis Measures’ Physical Functioning and Upper Extremity Scores

    Jun 1, 2024, 00:00

  • SA31 Fall-Related Risks with Pharmacological Interventions in Mild-to-Moderate Alzheimer’s Disease: A Bayesian Network Meta-Analysis

    Jun 1, 2024, 00:00

  • EE386 Restoration of Endodontically Treated Teeth: A Cost-Effectiveness Analysis of Endocrown Versus Complete Crown

    Jun 1, 2024, 00:00

  • MSR34 Diversity in Clinical Trials: Life Science Initiatives and Challenges in Light of the FDA’s Latest Guidance

    Jun 1, 2024, 00:00

  • CO2 Association Between Classes of Antidiabetic Medications and Their Potential Risk or Protective Effects on Cancer: A Systematic Review and Network Meta-Analysis

    Jun 1, 2024, 00:00

  • EE309 Cost-Effectiveness Analysis of Velmanase Alfa in Patients with Alpha Mannosidosis from a UK Health Service Perspective

    Jun 1, 2024, 00:00

  • EE101 Estimating the Burden of Osteogenesis Imperfecta on Patients and Healthcare Payers: A Health Economic Modelling Study

    Jun 1, 2024, 00:00

  • EPH163 Off-Label Use of Semaglutide in the United States: Increasing Prevalence, Variability in Prescribing Provider Specialty, and Patient Characteristics

    Jun 1, 2024, 00:00

  • SA10 The Safety and Effectiveness of Intraoperative Radiotherapy With Low-Energy X-Ray for Breast Cancer: A Systematic Review

    Jun 1, 2024, 00:00

  • CO143 Clinical Outcomes of First-Line (1L) Treatments (Txs) in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • EE350 Cost-Effectiveness Analysis of Xigduo (EXTENDED-RELEASE DAPAGLIFLOZIN-METFORMIN TABLETS) for Managing Type 2 Diabetes Mellitus (T2DM) Patients

    Jun 1, 2024, 00:00

  • HTA23 Caregiver Health-Related Quality of Life in National Institute for Health and Care (NICE) Appraisals: From Inception to 2023

    Jun 1, 2024, 00:00

  • CO106 Clinical Outcomes of Patients in the Intensive Care Unit with Infections Caused By Multiresistant Gram-Negative Bacteria in Colombian Patients

    Jun 1, 2024, 00:00

  • RWD163 Medication Adherence and Persistence on Selumetinib Treatment in Pediatric Patients: A US Claims Database Analysis

    Jun 1, 2024, 00:00

  • RWD182 AI-Assisted Chart Review to Understand Disease Flares in Systemic Lupus Erythematosus

    Jun 1, 2024, 00:00

  • MT48 Assessment of a Patient-Centric Web Application Tool for Potential Adverse Events of Oral Corticosteroids

    Jun 1, 2024, 00:00

  • HPR86 The Impact of Mandated Prescription Drug Monitoring Program Registration on Prescription Opioid-Related Mortality in California

    Jun 1, 2024, 00:00

  • PCR166 Real-World Discontinuation of High-Efficacy Disease Modifying Therapies for the Treatment of Multiple Sclerosis: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • EE332 Cost-Effectiveness Analysis of Implementing a Field Hospital during a Pandemic

    Jun 1, 2024, 00:00

  • CO161 Adherence and Persistence To Oral Targeted Therapies for Non-Small-Cell Lung Cancer and Association With Survival Outcomes

    Jun 1, 2024, 00:00

  • PCR31 Crosscultural Adaptation of the Hungarian Version of Stroke Impact (SIS)

    Jun 1, 2024, 00:00

  • HPR150 Beyond the Headline: Inflation-Adjusting ICER's Unsupported Price Increase Results

    Jun 1, 2024, 00:00

  • EE142 A Cost Utility Analysis of Zuranolone in the Treatment of Major Depressive Disorder

    Jun 1, 2024, 00:00

  • CO193 Real-World Retrospective Analysis Comparing a Bilayered Living Cellular Construct and a Fetal Bovine Collagen Dressing for Use in Venous Leg Ulcers

    Jun 1, 2024, 00:00

  • EPH224 Effectiveness of COVID-19 Vaccines in Colombia: Findings from Two Highly Specialized Healthcare Centers

    Jun 1, 2024, 00:00

  • RWD178 Costs of Cancer Care Across the Disease Continuum: An Analysis From a Health Payer Perspective in Brazil

    Jun 1, 2024, 00:00

  • HPR75 Can Multi-Cancer Early Detection Screening Result in Early Cancer Detection? A Modeling Study

    Jun 1, 2024, 00:00

  • RWD100 Assessing the Representativeness of Real-World Claims Databases

    Jun 1, 2024, 00:00

  • HPR44 Implications of Regulatory Telemedicine Prescribing Flexibilities on Patients With Opioid Use Disorder

    Jun 1, 2024, 00:00

  • EE278 Cost-Effectiveness Analysis of Premature Infant Oral Motor Intervention (PIOMI) in the Neonatal Intensive Care Unit in Colombia, 2022

    Jun 1, 2024, 00:00

  • EE129 Tools for the Critical Appraisal of Health Economic Analyses: A Scoping Review

    Jun 1, 2024, 00:00

  • HSD41 Disparities by Gender, Race and Geography Exist in Whether Patients Receive a Confirmatory Celiac Disease Endoscopy and Biopsy After Screening Positive

    Jun 1, 2024, 00:00

  • MSR100 Prediction Models for Cardiotoxicity Induced By Anticancer Drug in Women with Breast Cancer

    Jun 1, 2024, 00:00

  • RWD40 Concomitant Use of Opioids and Psychotropic Medications in Mississippi Medicaid Beneficiaries

    Jun 1, 2024, 00:00

  • EPH94 Healthcare Access and Health Equity Outcomes Among Adults With Cardiometabolic Conditions

    Jun 1, 2024, 00:00

  • RWD145 Healthcare Resource Utilization (HCRU) and Costs Among Previously-Treated Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Retrospective Analysis of SEER-Medicare Linked Claims

    Jun 1, 2024, 00:00

  • PCR149 Buprenorphine Adherence Trajectories, Persistence, and Healthcare Expenditures Among Commercially Insured Patients With Opioid Use Disorder

    Jun 1, 2024, 00:00

  • P48 Automating Economic Modelling: Potential of Generative AI for Updating Excel-Based Cost-Effectiveness Models

    Jun 1, 2024, 00:00

  • EPH160 A Risk Stratification Analysis of ASCVD Events Post-Statin Discontinuation in Bariatric Surgery Patients

    Jun 1, 2024, 00:00

  • EPH111 Diabetes' Prevalence by Gender, Age, and Race in the United States (Trends Between 2005 and 2019)

    Jun 1, 2024, 00:00

  • EE433 Why Economic Methods for Discounting Are Wrong, What Are the Consequences, and How to Fix It

    Jun 1, 2024, 00:00

  • HSD55 Real-World Medication Management of Adults With Sickle Cell Disease in the United States

    Jun 1, 2024, 00:00

  • EE260 Economic Analysis of a Low-Threshold Mobile Medical Unit Dispensing Buprenorphine for Opioid Use Disorder

    Jun 1, 2024, 00:00

  • CO151 A Preliminary Analysis of Oral Edaravone-Treated Patients With Amyotrophic Lateral Sclerosis Enrolled in a US-Based Administrative Claims Database

    Jun 1, 2024, 00:00

  • SA70 Identifying Early Disease Progression in Tricuspid Regurgitation When Echocardiographic Imaging Data Is Unavailable

    Jun 1, 2024, 00:00

  • HSD83 Multimorbidity Patterns and Related Treatment Costs Among Middle-Aged and Older Diabetes Patients in China

    Jun 1, 2024, 00:00

  • Health Equity Considerations in Economic Evaluations

    Jun 1, 2024, 00:00

  • EE300 Cost Effectiveness of Momelotinib Vs Other Treatments for Myelofibrosis from a US Payer Perspective

    Jun 1, 2024, 00:00

  • EE245 Budget Impact of Inotersen for the Treatment of Stage I or II Polyneuropathy in Adult Patients With Hereditary Transthyretin Amyloidosis (hATTR) in Public Health Mexico

    Jun 1, 2024, 00:00

  • PCR268 Association Between Screen Time, Social Support, and Mental Health in Adolescents: Evidence From a Nationally Representative Sample in 2022

    Jun 1, 2024, 00:00

  • RWD78 The Relationship of PROMIS Physical Function Scores, Healthcare Resource Utilization, and Charges in Patients Treated for Chronic Mechanical Low Back Pain

    Jun 1, 2024, 00:00

  • SA78 An Overview of Methods Employed in Economic Models of Cancer Screening Tests: A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • PCR68 Disparate Barriers to Care Among Ovarian Cancer Patients in Managing Their Sleep Disturbance and Fatigue

    Jun 1, 2024, 00:00

  • MT2 Operating Room (OR) and Sterilization Efficiencies for Total (TKA), Revision (rTKA) and Unicompartimental Knee Arthroplasty (UKA) Using a Handheld Robotic Assisted (RA) Surgical System

    Jun 1, 2024, 00:00

  • MSR68 Variability and Improvements of Answers Generated with Different Versions of Large Language Models

    Jun 1, 2024, 00:00

  • PT14 The Effectiveness of Bisphosphonates on Recurrent Osteoporotic Fractures Post-Denosumab Discontinuation Using Causal Machine Learning

    Jun 1, 2024, 00:00

  • EE509 Association between Body Mass Index and Medical Cost Among U.S. Adults in 2022

    Jun 1, 2024, 00:00

  • PCR180 Measuring and Valuing Child Health in Canada

    Jun 1, 2024, 00:00

  • EE138 Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: A Conceptual Framework

    Jun 1, 2024, 00:00

  • Economic Evaluation

    Jun 1, 2024, 00:00

  • PCR63 Public Deliberation on Health Gain Measures

    Jun 1, 2024, 00:00

  • RWD9 Anhedonia-Related Wording in Social Media: An Application of Natural Language Processing

    Jun 1, 2024, 00:00

  • PT21 A Generalized Framework for Eliciting Unreported Subgroup-Specific Events and Survival Outcomes from Aggregate Level Data: Analyses Advanced Stage Gastrointestinal Cancers

    Jun 1, 2024, 00:00

  • PCR233 Adherence and Persistence of Oral Anticoagulants for Treatment of Atrial Fibrillation across Stroke and Bleeding Risk Strata

    Jun 1, 2024, 00:00

  • RWD84 Changes in the Number of Hysterectomy Performed in Europe between 2010-2021

    Jun 1, 2024, 00:00

  • MSR88 The Influence of Social Determinants of Health on Healthcare Access, Utilization, and Treatments in Atopic Dermatitis Patients Using All of Us and Machine Learning Methods

    Jun 1, 2024, 00:00

  • MT11 Innovation in the Pharmaceutical Market: An Analysis of the Patents of Monoclonal Antibodies

    Jun 1, 2024, 00:00

  • HSD85 The Power of Click on Pharma Consumer: Navigating the Evolution and Challenges of Drug E-Commerce

    Jun 1, 2024, 00:00

  • PCR85 Are There Differences in the Sociodemographic Characteristics of Total Hip Arthroplasty Patients in Public and Private Health Care?

    Jun 1, 2024, 00:00

  • MT6 Clinical Significance of SP-D Biomarker in the Diagnosis of Connective Tissue Disease-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • RWD111 Implementing a Pilot Chart Abstraction Period Improves the Overall Accuracy Rate in Chart Abstraction

    Jun 1, 2024, 00:00

  • P22 Measuring Health-Related Quality of Life during Pregnancy: Exploring the Psychometric Properties of PROMIS to Assess Health-Related Quality of Life

    Jun 1, 2024, 00:00

  • HPR153 Improving Prediction of Medical Costs Among Medicare Beneficiaries By Incorporating Social Determinants of Health Indicators in Risk Prediction

    Jun 1, 2024, 00:00

  • PCR35 Impact of COVID-19 Vaccination with BNT162b2 on the Frequency of Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy

    Jun 1, 2024, 00:00

  • HPR136 Geographic Trends in Chimeric Antigen Receptor (CAR) T-Cell Therapy Access and Utilization

    Jun 1, 2024, 00:00

  • EE419 The Economic Burden of Thyroid Eye Disease in the Kingdom of Saudi Arabia

    Jun 1, 2024, 00:00

  • PCR181 Predicting COVID-19 Vaccine Hesitancy through Integrated Protection Motivation Theory Constructs

    Jun 1, 2024, 00:00

  • EE502 Healthcare Resource Utilization and Cost Burden in Patients with Primary Biliary Cholangitis

    Jun 1, 2024, 00:00

  • MSR65 The Benefits of a Complex Identification and Stratification Model for Depression: Insights from a Large Claims Analysis Study

    Jun 1, 2024, 00:00

  • P24 Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Employment and Work Productivity

    Jun 1, 2024, 00:00

  • EPH164 Results and Impact of the Acceleration Plan Implementation for Maternal Mortality Reduction in the Department of Bolívar, Colombia

    Jun 1, 2024, 00:00

  • RWD25 Trends and Utilization of Open, Laparoscopic, and Robotic-Assisted Appendectomy: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • PCR91 Patient Perspectives on Treatment Effectiveness in Psoriatic Arthritis: A Pilot Qualitative Study to Understand What Matters Most

    Jun 1, 2024, 00:00

  • EE135 Clinical and Economic Burden of Obesity in Low- and Middle-Income Countries: A Systematic Review

    Jun 1, 2024, 00:00

  • EE105 Cost-Effectiveness Analysis of Linperlisib for Relapsed or Refractory Follicular Lymphoma Based on Matching Adjusted Indirect Comparison in China

    Jun 1, 2024, 00:00

  • HSD22 Extending External Validity of Rcts and Meta-Analysis through Transportability Analysis and Integration of Mechanistic Research Evidence

    Jun 1, 2024, 00:00

  • P46 Can Large Language Models Simulate HTA Committee Discussions? Findings and Challenges from a Case Study in Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer

    Jun 1, 2024, 00:00

  • SA35 Assessing Meta-Analyses and Systematic Literature Reviews Comparing Effectiveness of Treatments for Relapsed/Refractory Multiple Myeloma (RRMM): A Targeted Literature Review From 2017-2023

    Jun 1, 2024, 00:00

  • EE36 Comparison of Healthcare Resource Utilization and Costs in Patients With Venous Thromboembolism Receiving Direct-Acting Oral Anticoagulants or Low Molecular Weight Heparins: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EE516 Estimating the Benefits of Reduced Fracture Incidence for Patients Living with Osteogenesis Imperfecta and for Healthcare Payers

    Jun 1, 2024, 00:00

  • HTA37 Digital Health Value Assessment Frameworks: An International Landscape

    Jun 1, 2024, 00:00

  • HPR65 Assessing Rare Disease Reimbursement Levels and Economic Burden on Patients in China

    Jun 1, 2024, 00:00

  • CO157 Characteristics of Medicare Beneficiaries With Multiple Administrations of CAR-T Therapy

    Jun 1, 2024, 00:00

  • EE394 Redefining the Scope: The Urgent Need for Holistic Multiple Sclerosis Modeling in Health Economics

    Jun 1, 2024, 00:00

  • EE435 Hospitalization Costs of Common Grade 3/4 Adverse Events Associated With Oncology Treatments in the United States

    Jun 1, 2024, 00:00

  • EPH51 Patient Characteristics and Treatment Patterns in Patients with Mantle Cell Lymphoma in China: A Real-World, Contemporary Cohort Study

    Jun 1, 2024, 00:00

  • CO181 Upadacitinib in Moderate-to-Severe Crohn's Disease (CD): A Systematic Review of Remission Outcomes in Adults With Inadequate Response or Intolerance to Biologic Drugs

    Jun 1, 2024, 00:00

  • CO133 A Propensity Score Matched Analysis Between an Infrarenal Fixation Device With ePTFE (Device A) and Two Suprarenal Fixation Devices With Dacron Fabric (Devices B and C)

    Jun 1, 2024, 00:00

  • OP3 The Upgrade of Educational System for Improving Practical Skills of Economics Graduate Students in HTA in Ukraine

    Jun 1, 2024, 00:00

  • CO113 The Financial Effect of Closing the Hypertension Blood Pressure Care Gap at Blue Cross and Blue Shield of Louisiana

    Jun 1, 2024, 00:00

  • PCR101 Characterizing the Experience of Caregiving for Those With Duchenne Muscular Dystrophy (DMD): Results From a Cross-Sectional Survey

    Jun 1, 2024, 00:00

  • HTA13 Survey Data in Value Demonstration: Acceptability within Health Technology Assessments in the UK

    Jun 1, 2024, 00:00

  • EPH187 Examinating the Safety of Recently Approved Drugs for Cardiovascular Disease Using A Large Database

    Jun 1, 2024, 00:00

  • RWD4 A Real-World Data Landscape Review of the 2023 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference

    Jun 1, 2024, 00:00

  • PCR266 Patient Preferences for Continuous Glucose Monitoring Devices: A Preliminary Study from People Living with Type 2 Diabetes

    Jun 1, 2024, 00:00

  • P2 Economic Burden and Healthcare Resource Utilization in Sjögren's Disease: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EPH230 County-Level Social Vulnerability Is Associated With Lower Pneumococcal Vaccine Uptake Among Medicare Beneficiaries in the United States (2016-2019)

    Jun 1, 2024, 00:00

  • HSD82 A Technology-Enabled Model to Define the Total Costs of Comprehensive Management of Hip and Knee Osteoarthritis: The Missing Link in Value Based Musculoskeletal Care

    Jun 1, 2024, 00:00

  • RWD41 Adherence Trajectories in Medicaid Drug-Naïve Type 2 Diabetes Patients: A Comparative Study between Initial Combination Therapy and Step-Therapy Approaches

    Jun 1, 2024, 00:00

  • SA77 Race and Ethnicity in Oracle EHR Real-World Data: A Contrast to Self-Reported Data in the United States

    Jun 1, 2024, 00:00

  • P32 Effective Data Visualization Techniques for Presenting Scenario Analysis Results in Health Economic Models

    Jun 1, 2024, 00:00

  • HTA22 Assessing Cost-Savings From the Inflation Reduction Act in Louisiana Medicare Beneficiaries Due to Diabetes Medications

    Jun 1, 2024, 00:00

  • SA6 Balancing Feasibility, Time, and Comprehensiveness: Approaches to Rapid Reviews of Health Economic Models

    Jun 1, 2024, 00:00

  • EE390 Economic Evaluation and Healthcare Resource Utilization (HCRU) Among Breast Cancer Patients Treated with Palbociclib: A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • RWD125 Evaluation of the Case-Mix-Index of Hungarian One-Day Surgical Treatment

    Jun 1, 2024, 00:00

  • CO77 A Systematic Literature Review of Real-World Treatment Effectiveness and Economic and Humanistic Burden in Patients with Muscle Invasive Bladder Cancer

    Jun 1, 2024, 00:00

  • EPH229 Inequalities According to Health Regime, in the Survival of Colorectal Cancer in a Colombian Caribbean City

    Jun 1, 2024, 00:00

  • EE449 Cost-Effectiveness Thresholds Around the World: How Brazil Positions Itself Compared to Other Countries

    Jun 1, 2024, 00:00

  • EPH50 Characterizing the Prevalence of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Among Adults ≥65 Years of Age in the United States (US) Using Three Real-World Cohorts

    Jun 1, 2024, 00:00

  • EE31 The Annual Economic Burden of PFO-Related Cryptogenic Stroke in the U.S.: A Cost-of-Illness Study

    Jun 1, 2024, 00:00

  • HPR98 Consumption of Hospital Resources in Intensive Care Units in Brazil: A Challenge for Health Financing

    Jun 1, 2024, 00:00

  • HSD77 Prescription Patterns for COVID-19 before the Availability of Antiviral Drugs Using the National Database of Health Insurance Claims in Japan

    Jun 1, 2024, 00:00

  • PCR205 Qualitative Analysis of Twitter Data on Attitudes of Men Who Have Sex with Men Related to Long Acting Injectable Prep

    Jun 1, 2024, 00:00

  • CO63 Real-World Comparative Effectiveness of the First COVID-19 mRNA Booster, mRNA-1273 Versus BNT162b2, Among US Medicare Fee-for-Service Non-Immunocompromised Beneficiaries Aged 65 and Older

    Jun 1, 2024, 00:00

  • RWD169 Prevalence of ANCA-Associated Vasculitis in Adults in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • HTA30 Evolution of Health Technology Assessment for Rare Diseases and Its Impact on Access

    Jun 1, 2024, 00:00

  • HPR138 A Non-Representative Sample: Racial and Ethnic Diversity in Clinical Trials of FDA-Approved Drugs

    Jun 1, 2024, 00:00

  • PCR28 Baseline Characterization of Patient-Reported Disease Burden in a Virtual, Longitudinal Cohort of Myasthenia Gravis

    Jun 1, 2024, 00:00

  • RWD91 Healthcare Resource Utilization and Costs Associated with COVID-19 in Colombia: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • PCR39 Exploring Patient and Caregiver Perspectives on Burden Associated with Friedreich Ataxia in the USA

    Jun 1, 2024, 00:00

  • HSD38 Factors Influencing Willingness To Utilize the Emergency Department Among Individuals Living With Sickle Cell Disease

    Jun 1, 2024, 00:00

  • EPH14 Association between the Use of Macrolide Antibiotics and Recurrent Wheezing in Hospitalized Infants with Bronchiolitis

    Jun 1, 2024, 00:00

  • PCR249 Understanding Caregiver Burden from Multiple Perspectives: Dyadic Agreement between Caregiver and Care Recipient

    Jun 1, 2024, 00:00

  • EE77 Non-Quality Costs of Unsafe Healthcare in a Hospital Institution

    Jun 1, 2024, 00:00

  • CO16 Shared Identity and Patient Care: Examining Racial and Gender Concordance on Treatment and Testing Adherence in CML

    Jun 1, 2024, 00:00

  • EE282 Cost-Equalization Approach to Estimate the Minimum Duration of Effect of Cell and Gene Therapies to Demonstrate Cost Savings to Payors: A Methodological Approach Using Late-Onset Pompe Disease

    Jun 1, 2024, 00:00

  • HPR63 Research and Development (RD) Investment By the Biopharmaceutical Industry: A Global Ecosystem Update

    Jun 1, 2024, 00:00

  • HTA33 Lung Cancer Health Technology Assessments Trends in Argentina, Brazil, Colombia, and Mexico

    Jun 1, 2024, 00:00

  • EE441 Cost-Effectiveness of a Comprehensive Team-Based Intervention for Pregnant Women with Diabetes: A Markov Cohort Study

    Jun 1, 2024, 00:00

  • EE58 Quantifying the Lifetime Economic Impact of Pediatric Oral Nutritional Supplements in Lower-Middle Income Countries in Asia

    Jun 1, 2024, 00:00

  • SA69 Enhancing the Value and Usefulness of Data Extracted From an Economic Systematic Literature Review

    Jun 1, 2024, 00:00

  • OP10 The Meteoric Rise of RWE and HEOR: Operating With Efficiency and Fostering Innovation Between the Two Groups

    Jun 1, 2024, 00:00

  • MSR101 A Novel Methodology for Assessing Response to Lymphoma Treatment in Real-World Studies – the Real-World Lugano (RWLUGANO) Study

    Jun 1, 2024, 00:00

  • EPH121 Prevalence and Correlates of Alcohol Use Disorder Diagnosis Among Cancer Survivors in the United States: Insights From a Real-World Study

    Jun 1, 2024, 00:00

  • HPR24 Understanding Pharmacy Benefit Manager (PBM) Adoption of Humira Biosimilars and Identifying Their Preferred Humira Biosimilars in Comparison with Humira

    Jun 1, 2024, 00:00

  • EE414 The Disparities in the Willingness to Pay for Health Benefits Between Prevention and Treatment Among Patients With Chronic Diseases in Saudi Arabia

    Jun 1, 2024, 00:00

  • EPH64 Assessing the Relationship Between Pain Intensity and Health Status Among Older US Adult Opioid Users With Pain

    Jun 1, 2024, 00:00

  • EE527 Is List Price the Key Driver of ICER Assessments? Exploring Drivers of Cost-Effectiveness

    Jun 1, 2024, 00:00

  • HSD70 Characteristics of Medicare Patients Initiating Long-Acting Injectable Antipsychotic Medications

    Jun 1, 2024, 00:00

  • P18 Assessing the Value of Revascularization Strategies for Chronic Limb Threatening Ischemia in Patients with Diabetic Foot Ulcers: A Propensity Score-Weighted Evaluation

    Jun 1, 2024, 00:00

  • EPH43 Systematic Review of Real-World Data: Assessing Cancer, Major Adverse Cardiovascular Events, Venous Thromboembolism, Infection, and Mortality Risk Associated With Jak Inhibitors in Rheumatoid Arthritis Patients in the United States

    Jun 1, 2024, 00:00

  • CO96 Evidence Gap Analysis of the Burden of Illness and Treatment of Thyroid Eye Disease

    Jun 1, 2024, 00:00

  • Pricing and Regulatory Policies: Implications for Pharmaceutical Manufacturers

    Jun 1, 2024, 00:00

  • PCR47 Characterization of Variability in Response Set Composition Across Pros: Insights for Reducing Complexity and Improving the Patient Experience of Clinical Research

    Jun 1, 2024, 00:00

  • RWD88 Exploring Patient Characteristics and Treatment in Real-World Endometrial Cancer Patients Users of Platinum Therapy

    Jun 1, 2024, 00:00

  • HTA24 Adopting a Societal Perspective in Health-Economic Evaluation: A Review of 9 HTA Methodological Guidelines on How to Integrate Societal Costs

    Jun 1, 2024, 00:00

  • PCR239 Perspectives on Pre-Exposure Prophylaxis (PrEP) Among People Who Could Benefit From PrEP: Qualitative Research Findings

    Jun 1, 2024, 00:00

  • EPH57 Prevalence of Hypertension Among Women Initiating a Combined Hormonal Contraception in the US

    Jun 1, 2024, 00:00

  • CO188 Fit-for-Purpose and Scalable Strategy to Address Mortality Completeness for Oncology Research: Comparison of Multiple Real-World Sources with the National Death Index

    Jun 1, 2024, 00:00

  • PCR140 Psychometric Validation of the QOL-B Respiratory Domain in Adults with Newly Diagnosed or Recurrent Mycobacterium avium Complex (MAC) Lung Disease: The ARISE and ENCORE Studies

    Jun 1, 2024, 00:00

  • PCR244 Prevalence of Plain-Language Summaries (PLS) in Open Access Patient-Reported Outcome (PRO) Publications

    Jun 1, 2024, 00:00

  • EPH117 Sociodemographic Factors Associated With E-Cigarette Use Among US Adults With Diabetes, Pre-Diabetes, or Risk of Diabetes

    Jun 1, 2024, 00:00

  • RWD51 The Added Value of Linking Real-World Data Sources

    Jun 1, 2024, 00:00

  • OP20 Objective Measurement of Quality of Life: First Results of the Project "Machine Intelligence for the Objective Determination of Individual Quality of Life" - MI-Lq

    Jun 1, 2024, 00:00

  • EE320 Budget Impact Analysis of TPMT and NUDT15 Pharmacogenomic Testing for 6-Mercaptopurine in Pediatric Acute Lymphocytic Leukemia Patients

    Jun 1, 2024, 00:00

  • EE11 Budget Impact Analysis of a Triple-Agent Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Topical Gel for the Treatment of Patients With Moderate-to-Severe Acne Vulgaris in the US

    Jun 1, 2024, 00:00

  • HTA32 Augmenting Health Economic Evidence Analysis: The Synergistic Role of AI in Deductive, Abductive Reasoning, and Insight Generation

    Jun 1, 2024, 00:00

  • EPH61 Timing of SGLT2 Inhibitor Initiation and Hospital Readmission in Acute Heart Failure With Type 2 Diabetes: A Target Trial Emulation Cohort Study

    Jun 1, 2024, 00:00

  • PCR247 Multidimensional Examination of Factors Determining Body Image Among Women of Reproductive Age in Hungary

    Jun 1, 2024, 00:00

  • CO97 Trial-and-Error Treatment Leads To Delayed Disease Control of Moderate-to-Severe Rheumatoid Arthritis

    Jun 1, 2024, 00:00

  • RWD126 Evaluation of the Importance of One-Day Surgical Treatment in Benign Gynecological Surgeries

    Jun 1, 2024, 00:00

  • P50 Increasingly Stringent Clinical Responses and the Association with Improvements in Pain, HRQoL, and Work Productivity in Patients with Hidradenitis Suppurativa: 16-Week Results from Phase 3 Studies BE HEARD III

    Jun 1, 2024, 00:00

  • EPH167 Real-World Treatment Patterns, Sequencing, and Unmet Need in Metastatic Colorectal Cancer (mCRC)

    Jun 1, 2024, 00:00

  • PCR4 Enhancing Quality of Life With Self-Administered Medication Over Intravenous Infusion Treatment in a Health System Specialty Pharmacy Setting

    Jun 1, 2024, 00:00

  • HPR127 Examine the Use of Real-World Evidence To Support FDA Decision-Making for New Drug Applications and Biologics License Applications From 2021 to 2022

    Jun 1, 2024, 00:00

  • EPH205 Frequency of Moderate to Severe Atopic Dermatitis and Clinical Characteristics in a Colombian HMO: Results for 2015-2022

    Jun 1, 2024, 00:00

  • EE91 Clinical Consequences and Associated Costs of Treating Patients With Chronic Lymphocytic Leukemia (CLL) With Bruton Tyrosine Kinase Inhibitors (BTKis) in the First-Line (1L) and Relapsed/Refractory (R/R) Settings

    Jun 1, 2024, 00:00

  • CO86 Real-World Evaluation of Intracardiac Echocardiography Guided Radio-Frequency Catheter Ablation for Atrial Fibrillation: A Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • RWD20 Enhancing Oncology Model: Discordance Among Patients Using Intravenous Iron in the US

    Jun 1, 2024, 00:00

  • EPH124 Examining the Effect of Hypertension, Type-2 Diabetes Mellitus, Hyperlipidemia, and Obesity on Endometrial Cancer Staging

    Jun 1, 2024, 00:00

  • EE304 Healthcare Resource Utilization and Cost of Care of Different IV Iron Treatments in Heart Failure Patients Diagnosed With Iron Deficiency/Iron Deficiency Anemia Using a Real-World Database

    Jun 1, 2024, 00:00

  • EE251 Effect of Anticholinergic Burden on Healthcare Costs in Patients With Overactive Bladder: A Retrospective Database Claims Analysis

    Jun 1, 2024, 00:00

  • HPR81 Multi-Stakeholder Approach to Rare Disease Care in Latin America

    Jun 1, 2024, 00:00

  • SA38 Adaptation of a Benefit Trade-Off Instrument to Elicit Inequality Aversion in the United States

    Jun 1, 2024, 00:00

  • EE130 Economic Burden of Seasonal Influenza in Mainland China from 2011 to 2019

    Jun 1, 2024, 00:00

  • HTA77 PICO Consolidation in European HTA Scoping: Examining PICO Variations in Oncology Drugs in the Context of the European Joint Clinical Assessment

    Jun 1, 2024, 00:00

  • SA51 A Non-Systematic Literature Review of Literature Reviews: Evaluation of Methods Implemented and Language Used to Describe Systematic and Non-Systematic Literature Reviews

    Jun 1, 2024, 00:00

  • MSR31 Comparison of Indirect Cost Calculations in Chronic Diseases and Caregivers Using the 2023 US National Health and Wellness Survey

    Jun 1, 2024, 00:00

  • EE161 The Economic Burden of BRCA+ Metastatic Castration Resistant Prostate Cancer: Expert Perspective in LATAM Countries

    Jun 1, 2024, 00:00

  • PCR79 Applying Conjoint Analysis to Explore the Preference of People in Choosing Self-Pay Health Check-up Services

    Jun 1, 2024, 00:00

  • HSD95 Utilization of Prescription Acquisition by Drive-Thru and Mail Before and During the COVID-19 Pandemic in the United States

    Jun 1, 2024, 00:00

  • HPR144 Optimization in Universal Health Coverage Design in South Africa Considering Both Health Outcomes and Health-Induced Poverty Outcomes

    Jun 1, 2024, 00:00

  • PCR186 Understanding the Participant Experience of Qualitative Interview Studies To Inform Future Study Design: Analysis of Feedback Forms

    Jun 1, 2024, 00:00

  • MSR6 Machine Learning Insights Into COVID-19 Variant Spread Across US Regions

    Jun 1, 2024, 00:00

  • EE352 Economic Burden of Prostate Cancer in the US: A Disease Stage-Based Cost Analysis

    Jun 1, 2024, 00:00

  • EE495 A Targeted Literature Review of Lung Function Decline in Idiopathic Pulmonary Fibrosis to Improve Survival Predictions in Cost-Effectiveness Analyses

    Jun 1, 2024, 00:00

  • PT22 Consistency Between Comparative Efficacy Estimates from Target Trial Emulations and Their Origin Target Trials: A Meta-Epidemiological Study

    Jun 1, 2024, 00:00

  • Health Service Delivery Process of Care

    Jun 1, 2024, 00:00

  • P15 A Review of Methods and Guidance for Considering Equity in Health Economic Research

    Jun 1, 2024, 00:00

  • EE345 Lifetime Cost-Effectiveness of Hereditary Breast and Ovarian Cancer Prevention Based on FinnGen and Biobank Data, Data Returning Process, and Prophylaxis

    Jun 1, 2024, 00:00

  • RWD190 The Impact of a Colorectal Cancer Diagnosis on Health Resource Utilization Patterns Among Patients With Hypertension Using Real-World Data

    Jun 1, 2024, 00:00

  • PCR222 Comparison of Recanalisation Therapies in Terms of Quality of Life in Ischaemic Stroke Patients in Hungary

    Jun 1, 2024, 00:00

  • CO32 Predictors of Overall Survival (OS) and Time to Next Treatment (TTNT) in Real-World Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) Patients Who Received First-Line (1L) Folfirinox (FFX) or Gemcitabine + Nab-paclitaxel (GnP)

    Jun 1, 2024, 00:00

  • PCR41 Exploration on Quality of Life of Caregivers of Patients With Bipolar Affective Disorder

    Jun 1, 2024, 00:00

  • HPR18 What Is the Impact of Including Outcomes-Based Agreements on the Cost-Effectiveness of Cell and Gene Therapies? A Case Example of Zynteglo for Transfusion-Dependent Beta Thalassemia

    Jun 1, 2024, 00:00

  • EE444 Target Trial Emulation with Real-World Data to Determine the Population-Level Cost-Effectiveness of Multi-Gene Panel Sequencing for Advanced Melanoma

    Jun 1, 2024, 00:00

  • EE311 Exploring Environmental Impacts of Switching Salmeterol/Fluticasone Propionate (SAL/FP) from Metered Dose Inhaler (MDI) to Dry Powder Inhaler (DPI) in Respiratory Illness in the United Kingdom

    Jun 1, 2024, 00:00

  • OP7 Health and Wellbeing in Teleworking: Exploring Key Factors

    Jun 1, 2024, 00:00

  • EE82 Health Care Resource Use Associated with Generalized Anxiety Disorder Among Adults in the United States

    Jun 1, 2024, 00:00

  • HTA79 Navigating the Clinical Effectiveness Challenges for Orphan Drug Assessments: A NCPE Review

    Jun 1, 2024, 00:00

  • EPH172 Humanistic and Economic Burden Among COPD Patients in China: How Does It Compare With Other Common NCDs?

    Jun 1, 2024, 00:00

  • EPH219 Understanding the Impact of Physical Exercise in People Living with Myasthenia Gravis from the MGFA Global MG Patient Registry (MGFAPR) in the US (2013-2023)

    Jun 1, 2024, 00:00

  • EE49 Public Health Impact and Cost-Effectiveness of a New Dengue Vaccine (TAK-003) in a Large Catch-up Cohort in Puerto Rico

    Jun 1, 2024, 00:00

  • PCR78 Treatment Preferences of Adult Patients With Attention-Deficit/Hyperactivity Disorder in Canada: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • EE38 Impact of Expenditure on Medicines for STD/AIDS on the Instituted Budget after the End of the Regime That Established a Ceiling on Public Expenditure in Brazil

    Jun 1, 2024, 00:00

  • MT30 Budget Impact of Improved Perioperative Reprocessing of Surgical Sets Used in Trauma Surgery in a Major German University Hospital

    Jun 1, 2024, 00:00

  • P44 Cost-Effectiveness of Eliglustat Tartrate for the Treatment of Type 1 Gaucher Disease in China Using a Semi-Markov Model

    Jun 1, 2024, 00:00

  • EPH138 Pneumococcal Vaccine Trends Among Older Adults in the United States from 2008 to 2022

    Jun 1, 2024, 00:00

  • EE60 The Excessive Burden of Low SES Caregivers: Evidence from Stroke Survivors Through CHARLS Data (2011-2018)

    Jun 1, 2024, 00:00

  • RWD55 Comparison of Real-World Outcomes Between a Clinical-Genomics Database and Other Real-World Databases Among Immunotherapy-Treated Patients With Advanced Non-Small Cell Lung Cancer (ANSCLC)

    Jun 1, 2024, 00:00

  • EE405 Residual Burden in Adalimumab-Treated Patients with Hidradenitis Suppurativa

    Jun 1, 2024, 00:00

  • RWD115 Is More Always Better? a Real-World Data Analysis of Hemoglobin A1C Data in Patients with Diabetes

    Jun 1, 2024, 00:00

  • P19 Negative Control Outcomes (NCOs) to Assess Comparability of Psoriasis (PsO) and Psoriatic Arthritis (PsA) Treatments

    Jun 1, 2024, 00:00

  • MSR96 Real-World Data Integration for Causal Inferen Benefits, Costs, and Case Studies

    Jun 1, 2024, 00:00

  • PCR132 Disparities in Patient Reported Outcomes Completion Rates and Baseline Function in Newly Presenting Spine Patients

    Jun 1, 2024, 00:00

  • PCR77 Postoperative Utilization of Other Orthopedic Services Adversely Affects Patient Reported Outcomes After Total Hip Arthroplasty

    Jun 1, 2024, 00:00

  • EE158 Economic Evaluation of Duvelisib Versus Ofatumumab in Relapsed/Refractory CLL/SLL in Japan

    Jun 1, 2024, 00:00

  • HSD103 Burden of Disease in Patients With Uncontrolled Gout in the USA

    Jun 1, 2024, 00:00

  • EE358 Systematic Literature Review of Cost-Effectiveness Analyses of Adult 15- and 20-Valent Pneumococcal Vaccines

    Jun 1, 2024, 00:00

  • RWD35 Assessing Pharmacoequity in PARPi Therapy Utilization and Outcomes in Ovarian Cancer Patients: Insights From Real-World Evidence

    Jun 1, 2024, 00:00

  • EE191 Economic Evaluation of Mental Health Interventions: A Cost-Consequence Analysis

    Jun 1, 2024, 00:00

  • EPH90 Health Characteristics and Adherence Patterns in Electronic Wearable Device Users: A Study in Low- and Middle-Income Countries

    Jun 1, 2024, 00:00

  • RWD123 Clinical and Hospital Related Outcomes of Journey II Knee System Compared to Other Knee Systems in the Management of Total Knee Arthroplasty (TKA) Patients

    Jun 1, 2024, 00:00

  • HPR139 Examining the Intersectionality of Race, Ethnicity, and Social Vulnerabilities in Predicting Severe Maternal Morbidities Among Blue Cross and Blue Shield of Louisiana Mothers

    Jun 1, 2024, 00:00

  • RWD101 Leveraging Ways of Working and Innovation Methodologies from the Technology Sector to Inform New Approaches to Health Equity Initiatives

    Jun 1, 2024, 00:00

  • CO69 Burden of Clinical Syndromes Associated with Pneumococcal Disease in Ecuador: A 2019 Perspective

    Jun 1, 2024, 00:00

  • EPH181 Real World Retrospective Analysis of Short-Term Disability Claims for the Genitourinary System in the United States

    Jun 1, 2024, 00:00

  • EPH86 Association of Long-COVID with Depression Among Adults in the United States

    Jun 1, 2024, 00:00

  • EPH218 The Clinical and Economic Epidemiology of Breast Cancer in Brazil from 2016 to 2022: A Real-World Evidence Study of 295,000 Outpatients in Public System

    Jun 1, 2024, 00:00

  • EE259 Care-Seeking Pattern and Costs of Health Services in Individuals with Multiple Chronic Conditions

    Jun 1, 2024, 00:00

  • EE277 Budget Impact Analysis of Anaprazole for the Treatment of Duodenal Ulcer in China

    Jun 1, 2024, 00:00

  • HTA65 How Does Conditional Regulatory Approval Affect the Reimbursement of Drugs in Canada?

    Jun 1, 2024, 00:00

  • EE393 Assessing Cost-Effectiveness in Diabetes Management: A US Healthcare Payer’s Perspective on 15MG Tirzepatide Versus 1MG Semaglutide

    Jun 1, 2024, 00:00

  • Critical Comments by Food and Drug Administration Reviewers on Patient-Reported Outcomes in Food and Drug Administration Regulatory Submissions (2018-2021) [Editor's Choice]

    Jun 1, 2024, 00:00

  • PCR207 Health-Related Quality of Life and Its Associate Factors Among Residents in Tianjin, China: Findings from 2023 National Health Service Survey

    Jun 1, 2024, 00:00

  • EE235 Health Care Related Costs of Treatment Delay Among Medicare Beneficiaries Diagnosed With Colon Cancer

    Jun 1, 2024, 00:00

  • HSD14 Characteristics of US Commercially Insured Patients with Type 2 Diabetes (T2D) Initiating Tirzepatide

    Jun 1, 2024, 00:00

  • HSD126 Diagnosing Rare Diseases: Referral Behaviors of Physicians in the United States

    Jun 1, 2024, 00:00

  • Understanding the National Institute for Health and Care Excellence Severity Premium: Exploring Its Implementation and the Implications for Decision Making and Patient Access [Editor's Choice]

    Jun 1, 2024, 00:00

  • CO192 A Retrospective Database Analysis of US Medicaid Treatment-Naive People With HIV (PWH) With or Without Mental Health Disorders (MHDs) Initiating Single-Tablet Regimens (STRs) Vs. Multi-Tablet Regimens (MTRs)

    Jun 1, 2024, 00:00

  • P38 Sources of Financial Support to Households Caring for Individuals with Duchenne Muscular Dystrophy: Results from a Caregiver Survey

    Jun 1, 2024, 00:00

  • EE81 Cost-Effectiveness Analysis of Pegmolesatide Compared to Darbepoetin in Patients With Anemia Caused by Chronic Kidney Disease: The Case of China

    Jun 1, 2024, 00:00

  • P59 A Microsimulation Model for High-Risk Stage II and Stage III Colon Cancer Survivors Following the Current Guidelines

    Jun 1, 2024, 00:00

  • PCR8 Comparison of the Sociodemographic Characteristics and Various Indicators of Patients with Acute Ischemic Stroke

    Jun 1, 2024, 00:00

  • SA66 Patient Demographic and Clinical Characteristics Associated With the Use of the Newly Approved Disease-Modifying Medications for Sickle Cell Disease

    Jun 1, 2024, 00:00

  • SA42 Cognitive Impairment and Cardiovascular Disease in Older Adults: An Evaluation Using Pooled Observational Data

    Jun 1, 2024, 00:00

  • PCR13 Bridging the Gap: User Engagement in Developing and Implementing Digital Medication Adherence Technologies

    Jun 1, 2024, 00:00

  • CO120 Progression of Disease Burden Among Boys with Duchenne Muscular Dystrophy (DMD) According to Ambulatory Status and Age at Loss of Ambulation (LoA)

    Jun 1, 2024, 00:00

  • EE425 A Comparison of Payer Costs for Patients with and without Revascularization in Thoracic Endovascular Aortic Repair Stent Grafting Procedures

    Jun 1, 2024, 00:00

  • PCR11 The Impact and Burden of Visual Impairment in Patients With Dry Age-Related Macular Degeneration Relative to Older Adults Without Major Eye Conditions: A Qualitative Interview Study

    Jun 1, 2024, 00:00

  • EE181 Impact of Type 1 Diabetes on Productivity and Out-of-Pocket Costs of Adult Continuous Glucose Monitoring Users in the United States: Results From a Cross-Sectional Survey in the United States

    Jun 1, 2024, 00:00

  • MT24 The State of Single-Use Ureteroscopy in the United States

    Jun 1, 2024, 00:00

  • EE411 Cost-Effectiveness of Venetoclax in Combination with Azacitidine in Unfit Patients With Previously Untreated Acute Myeloid Leukemia in China

    Jun 1, 2024, 00:00

  • P14 Health Equity Impacts of Alteplase for Ischemic Stroke in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • EE469 Societal Costs of Alzheimer's Disease: Informal Caregiver Burden and Patient Productivity Loss

    Jun 1, 2024, 00:00

  • PCR208 The Association of Intentional Weight Reduction with Symptom Burden and PRO Measures in Patients with Obstructive Sleep Apnea: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • PCR135 Humanistic Burden of Fabry Disease and Associated Utility Values

    Jun 1, 2024, 00:00

  • HSD18 Patients' Perceptions of Safety of the Health Care in a Large Hospital Institution in Barranquilla, Colombia

    Jun 1, 2024, 00:00

  • EE496 Cost of Anti-CD38 Monoclonal Antibodies in Combination With Carfilzomib and Dexamethasone for Relapsed Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • HTA71 Cost-effectiveness of The Top 100 Drugs By Public Spending in Canada, 2015-2021: A Repeated Cross-sectional Study

    Jun 1, 2024, 00:00

  • Logical Inconsistencies With Expected Utility Theory May Align Better With Patient Preferences—A Response to Paulden et al

    Jun 1, 2024, 00:00

  • MT43 The Economic Impact of Screening Mammogram Image Quality-Related Retakes and Recalls: A Modeling Study from the Provider Perspective

    Jun 1, 2024, 00:00

  • EE86 Cost-Effectiveness of Tivozanib in Advanced Renal Cell Carcinoma in the US

    Jun 1, 2024, 00:00

  • RWD120 Evaluating the Impact of Human Growth Hormone (HGH) Drug Shortages on Patient Treatment Switching Patterns Using Real-World Data

    Jun 1, 2024, 00:00

  • EE3 Cost Effectiveness Model on Four Preventive Treatment for Clostridioides Difficile Infection Recurrence From a US Payer Perspective

    Jun 1, 2024, 00:00

  • EE247 Budget Impact of Infliximab Subcutaneous from the US Healthcare Perspective

    Jun 1, 2024, 00:00

  • PCR38 Health-Related Quality of Life Associated with Generalized Anxiety Disorder Among Adults in the United States

    Jun 1, 2024, 00:00

  • HTA26 Economic Evaluation Submitted for Reimbursement in the Brazilian Unified Health System: A Meta-Epidemiological Study

    Jun 1, 2024, 00:00

  • HSD57 Current Status of Off-Label IV Ketamine Utilization for Mood Disorders: A Nationwide Survey of Ketamine Clinics, Treatment Processes, and Provider Perceptions of Outcomes

    Jun 1, 2024, 00:00

  • Table of Contents

    Jun 1, 2024, 00:00

  • EE78 Economic and Comorbidity Burden of Prurigo Nodularis and Drivers of Higher Healthcare Costs in the US: A Retrospective Analysis of Claims Data of Patients Diagnosed Between 2017 and 2022

    Jun 1, 2024, 00:00

  • EE356 Economic Burden of Diseases Caused By Overweight and Obesity in Mexico

    Jun 1, 2024, 00:00

  • EPH120 Incidence, Prevalence and Clinical Characteristic of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study

    Jun 1, 2024, 00:00

  • CO154 Prevalence of Unmet Social Needs and Post-Transplant Outcomes Among Adult Sickle Cell Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

    Jun 1, 2024, 00:00

  • EE368 Claims-Based Comparison of Characteristics and Healthcare Costs Between Mothers With and Without Postpartum Depression

    Jun 1, 2024, 00:00

  • EPH139 Adverse Events Associated with Enzyme Replacement Therapies Lysosomal Glycogen-Specific Enzyme (GAA) Medications for the Treatment of Pompe Disease

    Jun 1, 2024, 00:00

  • Modeling for HTA

    Jun 1, 2024, 00:00

  • HPR83 The Distribution and Influential Factors Analysis of National Price-Negotiated Drugs in Medical Institutions and Pharmacies in China: A Case Study of Hyperkalemia

    Jun 1, 2024, 00:00

  • SA27 Reduction in Corticosteroid Use Among Patients With Focal Segmental Glomerulosclerosis, Membranous Nephropathy, or IgA Nephropathy after Acthar® Gel in a Large Administrative Claims Database

    Jun 1, 2024, 00:00

  • EE378 Economic Burden of Non-Hodgkin Lymphoma Among Patients with Commercial Insurance

    Jun 1, 2024, 00:00

  • EPH63 Epidemiological Disease Burden of Female Infertility of Other Origin Based on Routinely Collected Health Insurance Claims Data between 2010-2019

    Jun 1, 2024, 00:00

  • EPH85 Machine Learning-Based Prediction of Unplanned Readmission Due to Major Adverse Cardiovascular Events (MACE) Among Hospitalized Patients With Blood Cancers

    Jun 1, 2024, 00:00

  • Clinical Outcomes

    Jun 1, 2024, 00:00

  • HSD21 Relationships Between Census Tract-Level Social Determinants of Health and Cardiovascular Care Among Individuals Diagnosed With Breast Cancer

    Jun 1, 2024, 00:00

  • RWD154 Evaluation of Mortality Data Sources for Use in Real-Word Data Analyses

    Jun 1, 2024, 00:00

  • EE80 The Health Equity Impact of a Hypothetical Disease-Modifying Treatment for Alzheimer's Disease in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • HSD123 Prescription Opioid Dispensings in Medicare Part D in 2020 by US Region and Prescriber Type

    Jun 1, 2024, 00:00

  • CO94 Advancing Diabetes Care: Novel Drug Interventions in the Management and Control of Type 2 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • EE33 Cost-Effectiveness of Aducanumab, Lecanemab, and Donanemab for Early Alzheimer Disease in the US

    Jun 1, 2024, 00:00

  • EE458 Economic Burden of Disease Recurrence in Elderly Patients With Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Early Breast Cancer (eBC)

    Jun 1, 2024, 00:00

  • HTA59 Reception of RWE: A Deep Dive Into Recent Trends in CADTH Reimbursement Reviews

    Jun 1, 2024, 00:00

  • CO62 Clinical Outcomes of Second-Line (2L) Treatments (TXS) in Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • CO104 Clinical Outcomes of Second-Line and Beyond (2L+) Treatments (TXS) in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • RWD67 Influenza's Impact on Heart Failure Patients: A Ten-Year Analysis

    Jun 1, 2024, 00:00

  • HPR104 How Well Can Insurers Police Off-Label Use? Evidence from GLP-1s in Medicare Part D

    Jun 1, 2024, 00:00

  • EE303 Economic Costs of Informal Care for Individuals with Disabilities and Chronic Diseases in Hong Kong

    Jun 1, 2024, 00:00

  • EE70 The Cost of Chronic Lung Allograft Dysfunction (CLAD) in Lung Transplant (LTx) Recipients By Stage 0-4: A Claims Database Analysis

    Jun 1, 2024, 00:00

  • HSD104 Semaglutide and Tirzepatide in Type 2 Diabetes: Patient Characteristics and Weight-Related Outcomes in the Real-World Setting

    Jun 1, 2024, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • 10
  • »